COVID-19 Anomaly: recovered patients retest positive for viral infection

The valued scientific method of Lyndon H. LaRouche, Jr. may well become the sole avenue through which a competent, much needed comprehension of how to halt COVID- 19’s deadly specter around the globe will happen.   

More questionable, rather than definitive, findings continue to emerge regarding crucial facets of COVID-19 (SARS-Cov-2).  Disturbing and of great concern is an “Assessment of patients who tested positive after recovery,” covered in a Lancet-published scientific paper July 6, 2020. This assessment records ”[a] follow up of 23 (3%) of 651 patients [who] tested positive on a retest for SARS-CoV-2,” the virus which causes COVID-19, in a routine health check.

These patients were among the 651 recovered, who did not manifest symptoms for three days, and tested negative twice for SARS-CoV-2 at least one day apart, at the Wuhan Pulmonary Hospital (Wuhan, China). “The median duration from hospital discharge to a positive retest was 15.0 days. The median duration from a positive retest to hospital re-admission was 1-5 days. Among this retest positive group 15 patients (65%) were asymptomatic at the time of retest whereas eight (35%) had at least one symptom associated with active COVID-19. Specifically, six patients (26%) presented with fever, two (9%) had a cough, one (4%) reported fatigue, one (4%) dyspnea, and one (4%) had chest tightness.”

The study authors state “the positive retest in the symptomatic patients suggests the potential for recurrence of active disease and its transmission,” while although the asymptomatic patients’ PCR [polymerise chain reaction] test was positive upon retest, their results “only reflect residual non-pathogenic viral components.”   PCR detects the genetic information of the virus – its RNA and reveals whether or not someone has the virus before antibodies form or symptoms of the disease are present.

At the time of the last follow up, April 4, 2020, no new viral transmission could be ascribed to these patients with a positive retest, which the authors attribute to the practice of precautionary discharge measures where patients are discharged from the hospital to a large-scale intermediary, temporary shelter hospital, rather than directly back into the public or home setting. Shelter hospitals are a novel concept to be incorporated into the design of public health measures whereas responses to COVID-19 treatment, recovery and preventive measures are to be addressed.

Published by Cloret

Longtime activist and associate of American physical economist Lyndon H. LaRouche, Jr. Worked in clinical trials for hemoglobinopathies for 10+ years compiling data and assisting in manuscript preparation for publishing outcomes in peer-review journals.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: